Introduction
Lysolecithin (lysophosphatidyl choline, LPC) is present in human bile in patients with cholecystitis and has long been implicated in the pathogenesis of cholecystitis. [1] [2] [3] [4] [5] [6] In animals LPC instilled into the lumen of the gall-bladder produces gall-bladder inflammation with the process mediated by eicosanoids. Platelet-activating factor (1-alkyl-2-acetyl-SN-glycero-3-phosphocholine, PAF) is a purported mediator of inflammation and has been found to produce experimental cholecystitis in animals.
The purpose of this study was to evaluate the effect of LPC on human gall-bladder mucosal cell prostanoid and PAF formation. Prostanoids and PAF are both products of the phospholipase a metabolic pathway. 1 It was anticipated that demonstrating alterations in PAF formation would suggest that LPC produces its effect by stimulating phospholipase A activity, as well as by altering cyclooxygenase activity.
Materials and Methods
With the approval of the St Louis University Insti- tutional Review Board as well as informed consent, 17 patients undergoing routine cholecystectomy took part in this study. The mean (+ S.E.M.) age of the seven males and ten females was 47 (+ 3) years. All specimens were opened in the operating room and the mucosal surface evaluated by a pathologist to ensure that the gall-bladder had no areas that were indicative of neoplasms. Stones were present in seven of the gall-bladders, while ten did not have stones and were removed incidentally at the time of liver or pancreatic resections. Six of the gall-bladders with stones were removed by laparoscopy. The gallbladders used were selected to obtain specimens with minimal inflammation and thus provide greater mucosal cell yields.
Gall-bladder mucosal cell isolation and culture were performed as described previously.
11 Gall-bladder specimens were maintained in 0. 
Results
The effect of varying concentrations of LPC on gallbladder mucosal cell integrity was evaluated in a variety of ways. LDH is a lysosomal enzyme commonly measured in tissue culture media as an index of the amount of cellular contents lost through damaged cell membranes. 16 As seen in Table 1 (Fig. 1) . As seen in Fig. 2 , LPC treatment induced increased expression of inducible COX-2 as demonstrated by the rabbit anti-COX-2 antibody.
These results support the conclusion that LPC stimulates de novo synthesis of 72 kDa inducible COX-2 enzyme 19,2 in human gall-bladder mucosal cells.
Discussion
The results of the present study suggest that a cytolytic, membrane perturbing substance present in bile, LPC, produces significant changes in COX and phospholipase a metabolism by human gall-bladder mucosal cells. While the changes in LDH levels indicate some limited membrane damage may be occurring, 21 the evidence suggests that LPC has direct stimulatory activity on phospholipase A and COX enzymes. Support for this conclusion is related to the specificity of the changes in PAF and prostanoid formation with increased prostacyclin formation and the increased expression of inducible COX-2 in response to LPC stimulation.
COX-1 protein was not detectable or barely detectable and did not appear to be inducible by LPC. This is true in other systems as well. In skin inflammation, 
